China Orders Abbott Formula Recall Over Botulism Risk

by Christopher Freeburn | August 6, 2013 9:59 am

China Orders Abbott Formula Recall Over Botulism Risk

ChinaFlag 300x225 China Orders Abbott Formula Recall Over Botulism Risk[1]Chinese regulators have asked an American firm to pull two products from the market[2].

On Tuesday, the General Administration of Quality Supervision, Inspection and Quarantine requested that Abbott Laboratories (ABT[3]) recall two batches infant formula after New Zealand’s embassy warned that some of the formula could contain a harmful bacteria, the Wall Street Journal notes.

The regulator said that formula, which use ingredients from New Zealand’s Fonterra Co-Operative Group, a diary farm, may have been contaminated by Clostridium botulinum, which causes botulism, a potentially debilitating and fatal disease.

Chinese regulators are also recalling a number of other food and beverage products containing potentially contaminated Fonterra ingredients across China.

Last month, Chinese authorities arrested a number of GlaxoSmithKline (GSK[4]) employs for allegedly paying illicit incentives to physicians to prescribe the company’s drugs[5].

Shares of Abbott Laboratories fell modestly in Tuesday morning trading.

Endnotes:
  1. [Image]: http://investorplace.com/wp-content/uploads/2012/04/ChinaFlag.jpg
  2. to pull two products from the market: http://online.wsj.com/article/BT-CO-20130805-713987.html?mod=googlenews_wsj
  3. ABT: http://studio-5.financialcontent.com/investplace/quote?Symbol=ABT
  4. GSK: http://studio-5.financialcontent.com/investplace/quote?Symbol=GSK
  5. allegedly paying illicit incentives to physicians to prescribe the company’s drugs: http://investorplace.com/2013/07/police-detain-glaxosmithkline-staff-in-3-cities/

Source URL: http://investorplace.com/2013/08/china-orders-abbott-formula-recall-over-botulism-risk/
Short URL: http://invstplc.com/1fv5BFZ